SMi's 4th Annual 3D Cell Culture Conference

SMi's 4th Annual 3D Cell Culture Conference in London on Tuesday, February 18, 2020
SMi's 4th Annual 3D Cell Culture Conference in London on Tuesday, February 18, 2020
Tuesday, February 18, 2020 -- Thursday, February 20, 2020, 0830 - 1730
CHAIRED BY:
Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
Stefan Przyborski, Professor of Cell Technology, Durham university

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

Bioprinting has become increasingly efficient and accurate in building in vitro tissue models with the potential to provide pathologically relevant responses and model human disease mechanisms. Bio-printed structures yield phenotypic endpoints that are comparable with clinical studies and can provide a realistic prediction of clinical efficacy. The use of bioprinting is growing in big pharma companies as an alternative to organ-on-a-chip systems.

For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.

WHO SHOULD ATTEND?
Biotech / Pharma Companies - Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor - Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director

Tickets https://go.evvnt.com/520854-1?pid=2874
Brochure https://go.evvnt.com/520854-3?pid=2874
Inquiries https://go.evvnt.com/520854-4?pid=2874
Website https://go.evvnt.com/520854-5?pid=2874
Sponsor https://go.evvnt.com/520854-6?pid=2874

Prices:
Conference & Focus Day GBP 2398.00
Conference Only GBP 1499.00
Focus Day Only GBP 899.00
Promotional Literature Distribution at event GBP 999.00
Documentation - Conference Presentations GBP 499.00

Speakers: Petra Kerscher, Senior Scientist, Merck KGaA, Amna Magzoub, R&D Engineer, Novo Nordisk A/S Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Stefan Przyborski, Professor of Cell Technology, University of Durham, Philip Hewitt, UK and Eutrotox Registered Toxicologist, Head of Early Investigative Technology, Merck, Amna Magzoub, R&D Engineer, Novo Nordisk A/S, Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Sarah Trenfi eld, Director of Innovation, FabRx Ltd, Hansjoerg Keller, Senior Investigator I, Musculoskeletal Disease Area, Novartis, Jason Ekert, Head Complex In Vitro Models, GSK, Petra Kerscher, Senior Scientist, Merck, Hansjoerg Keller, Senior Investigator I, Novartis, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University Gino Van Heeke, CSO, Engitix, Naheem Yaqub, PhD Candidate, University College London in Collaboration with GSK, Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur, Floriane Groell, Senior Scientist, Novartis Pharma AG, Samuel Jackson, Programme Manager, Disease Models Efficacy and Safety Pharmacology, NC3Rs, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University, Maxime Feyeux, Co-Founder, President, CSO, TreeFrog Therapeutics, Michele Zagnoni, Reader, University of Strathclyde, Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, MHRA, Wendy Rowan, Scientific Director, Novel Human Genetics Research Unit, GSK, Alexander D. Graham, Investigator Scientist, MRC Harwell Institute, Ellen J. Wehrens, Scientific Writer, Imaging Department, Princess Máxima Center for Pediatric Oncology, Rajesh Pandey, Postdoctoral Training Fellow, MRC Harwell Institute
Starting Price Per Person
£ 499.00 GBP
Other Information
Where
Copthorne Tara Hotel London Kensington
Scarsdale Place
London W8 5SY
United Kingdom

                 
Event Organizer Contact
Simi Sapal
ssapal@smi-online.co.uk
02078276000
More Events
Event ID: 161393

Get Events in Your Inbox

We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox


  •    
  •